Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2014

Jun 3, 2014

31971_dirs_2014-06-03_30cbb912-b009-4b2c-9dd6-d0e7defb1651.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-06-01

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-06-01 Common Stock M 800 Acquired 8197 Direct
2014-06-01 Common Stock F 289 $44.90 Disposed 7908 Direct
2014-06-01 Common Stock M 800 Acquired 8708 Direct
2014-06-01 Common Stock F 289 $44.90 Disposed 8419 Direct
2014-06-01 Common Stock M 800 Acquired 9219 Direct
2014-06-01 Common Stock F 289 $44.90 Disposed 8930 Direct
2014-06-01 Common Stock M 800 Acquired 9730 Direct
2014-06-01 Common Stock F 289 $44.90 Disposed 9441 Direct
2014-06-01 Common Stock M 800 Acquired 10241 Direct
2014-06-01 Common Stock F 289 $44.90 Disposed 9952 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-06-01 Rsus (restricted Stock Units) $0 M 800 Disposed 2019-06-01 Common Stock (800) Direct
2014-06-01 Rsus (restricted Stock Units) $0 M 800 Disposed 2020-06-01 Common Stock (800) Direct
2014-06-01 Rsus (restricted Stock Units) $0 M 800 Disposed 2021-06-01 Common Stock (800) Direct
2014-06-01 Rsus (restricted Stock Units) $0 M 800 Disposed 2022-06-01 Common Stock (800) Direct
2014-06-01 Rsus (restricted Stock Units) $0 M 800 Disposed 2023-06-01 Common Stock (800) Direct
2014-06-01 Rsus (restricted Stock Units) $0 A 3250 Acquired 2024-06-01 Common Stock (3250) Direct
2014-06-01 Sars (Stock Appreciation Rights) $44.90 A 7800 Acquired 2024-06-01 Common Stock (7800) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.